Keyword: COVID-19


BARDA Funds Gritstone Bio's Phase 2b Study for Covid-19 Vaccine Candidate

28.09.2023 -

US biotechnology company Gritstone Bio has received a contract from the US Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase 2b...


CSPC Pharmaceutical and Pfizer to Launch Local Brand of Paxlovid in China

03.07.2023 -

Chinese drugmaker CSPC Pharmaceutical announced on Jun. 28, 2023, that it has signed a strategic partnership agreement with Pfizer to launch a local brand of the Covid-19...


EU and Pfizer/BioNTech Amend Vaccine Pact

30.05.2023 -

The European Commission and vaccine makers Pfizer and BioNTech have reached agreement on amending the bloc’s 2021 supply deal for the duo’s Comirnaty mRNA-based shot. The...


FDA Grants Full Approval to Pfizer’s Paxlovid

26.05.2023 -

Pfizer's oral anti-viral Covid-19 treatment Paxlovid has won full approval from the US Food and Drug Administration (FDA) after Emergency Use Authorization was granted in...


Positive Vaccine Data Bolster Novavax

16.05.2023 -

The market value of US vaccine maker Novavax is gaining momentum again on the back of promising data the company recently provided on its combined Covid and flu vaccine...


UK Health Records Underpin Vaxzevria Concerns

31.03.2023 -

An analysis of British records for December 2020-May 2022 is said to show that young women aged 12-29 who received at least one dose of AstraZeneca’s Covid vaccine may...

Logistics & Supply Chain

Centrally Controlled Logistics for Covid-19 Vaccines

16.03.2023 -

Examples of national logistics solutions in the UK, the Netherlands and Belgium show how high availability and low costs can be brought down to a common denominator.


US Uncovers Covid-related Bogus API-making Deals

03.03.2023 -

Under US president Joe Biden, the Department of Justice has been moving energetically of late to uncover and prosecute offenses that might otherwise have been swept under...